Concepts (93)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Subarachnoid Hemorrhage | 10 | 2021 | 108 | 5.410 |
Why?
|
| Brain Ischemia | 8 | 2021 | 417 | 3.560 |
Why?
|
| Genome-Wide Association Study | 5 | 2022 | 359 | 1.640 |
Why?
|
| Brain Injuries, Traumatic | 2 | 2023 | 97 | 1.440 |
Why?
|
| Intracranial Aneurysm | 5 | 2022 | 366 | 1.310 |
Why?
|
| Neuroblastoma | 1 | 2023 | 52 | 0.810 |
Why?
|
| Neural Stem Cells | 1 | 2023 | 48 | 0.800 |
Why?
|
| Brain Concussion | 1 | 2023 | 36 | 0.790 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2022 | 491 | 0.770 |
Why?
|
| Vasospasm, Intracranial | 3 | 2020 | 30 | 0.770 |
Why?
|
| Mitochondria | 3 | 2023 | 371 | 0.740 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2021 | 24 | 0.730 |
Why?
|
| DNA Methylation | 2 | 2020 | 292 | 0.710 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2022 | 718 | 0.710 |
Why?
|
| Autophagy | 2 | 2023 | 225 | 0.650 |
Why?
|
| Endothelin Receptor Antagonists | 1 | 2018 | 1 | 0.610 |
Why?
|
| Dioxanes | 1 | 2018 | 5 | 0.610 |
Why?
|
| Cognitive Dysfunction | 1 | 2023 | 331 | 0.610 |
Why?
|
| Tetrazoles | 1 | 2018 | 22 | 0.600 |
Why?
|
| Haptoglobins | 1 | 2018 | 13 | 0.580 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2018 | 31 | 0.580 |
Why?
|
| Pyridines | 1 | 2018 | 111 | 0.570 |
Why?
|
| SOXF Transcription Factors | 1 | 2017 | 11 | 0.570 |
Why?
|
| Pyrimidines | 1 | 2018 | 137 | 0.560 |
Why?
|
| Hydrocephalus | 1 | 2018 | 43 | 0.560 |
Why?
|
| Sulfonamides | 1 | 2018 | 127 | 0.560 |
Why?
|
| Computed Tomography Angiography | 1 | 2018 | 123 | 0.540 |
Why?
|
| Cerebral Infarction | 3 | 2021 | 83 | 0.510 |
Why?
|
| Cerebral Angiography | 1 | 2018 | 290 | 0.500 |
Why?
|
| Stroke | 1 | 2021 | 1192 | 0.380 |
Why?
|
| Humans | 18 | 2023 | 63304 | 0.360 |
Why?
|
| Spectroscopy, Near-Infrared | 2 | 2021 | 41 | 0.350 |
Why?
|
| Biomarkers | 3 | 2020 | 1397 | 0.330 |
Why?
|
| Databases, Bibliographic | 2 | 2018 | 9 | 0.300 |
Why?
|
| Mice, Inbred C57BL | 3 | 2023 | 3388 | 0.270 |
Why?
|
| Male | 10 | 2023 | 29829 | 0.270 |
Why?
|
| Cyclooxygenase 2 | 2 | 2023 | 75 | 0.250 |
Why?
|
| RNA, Messenger | 2 | 2023 | 1537 | 0.240 |
Why?
|
| Middle Aged | 7 | 2023 | 17555 | 0.230 |
Why?
|
| Treatment Outcome | 3 | 2021 | 5657 | 0.220 |
Why?
|
| Female | 9 | 2023 | 32801 | 0.210 |
Why?
|
| Moyamoya Disease | 1 | 2023 | 12 | 0.210 |
Why?
|
| Prospective Studies | 3 | 2019 | 3284 | 0.190 |
Why?
|
| Caspases | 1 | 2023 | 174 | 0.190 |
Why?
|
| Protein Interaction Maps | 1 | 2022 | 35 | 0.190 |
Why?
|
| Hydrogels | 1 | 2023 | 115 | 0.180 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2023 | 619 | 0.180 |
Why?
|
| Cerium | 1 | 2021 | 4 | 0.180 |
Why?
|
| Bayes Theorem | 1 | 2022 | 122 | 0.180 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2023 | 172 | 0.180 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2021 | 30 | 0.180 |
Why?
|
| Cerebrospinal Fluid | 1 | 2021 | 24 | 0.180 |
Why?
|
| Republic of Korea | 2 | 2022 | 160 | 0.180 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2023 | 258 | 0.180 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2021 | 135 | 0.170 |
Why?
|
| Mice | 3 | 2023 | 10815 | 0.170 |
Why?
|
| Cerebral Hemorrhage | 1 | 2021 | 97 | 0.170 |
Why?
|
| Cadherin Related Proteins | 1 | 2020 | 3 | 0.170 |
Why?
|
| Receptor, Insulin | 1 | 2020 | 50 | 0.170 |
Why?
|
| Monitoring, Physiologic | 1 | 2021 | 158 | 0.160 |
Why?
|
| Cadherins | 1 | 2020 | 80 | 0.160 |
Why?
|
| Epigenesis, Genetic | 2 | 2020 | 385 | 0.160 |
Why?
|
| Receptor, Endothelin A | 1 | 2019 | 1 | 0.160 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 207 | 0.160 |
Why?
|
| DNA, Intergenic | 1 | 2019 | 24 | 0.160 |
Why?
|
| Rats | 1 | 2023 | 1977 | 0.160 |
Why?
|
| Thrombectomy | 1 | 2021 | 234 | 0.160 |
Why?
|
| CpG Islands | 1 | 2020 | 216 | 0.150 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2019 | 40 | 0.150 |
Why?
|
| Antigens, CD | 1 | 2020 | 347 | 0.150 |
Why?
|
| Risk Factors | 2 | 2018 | 5344 | 0.140 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2017 | 4 | 0.140 |
Why?
|
| Case-Control Studies | 2 | 2017 | 1120 | 0.140 |
Why?
|
| Neurons | 1 | 2023 | 922 | 0.130 |
Why?
|
| Aneurysm, Ruptured | 1 | 2017 | 73 | 0.130 |
Why?
|
| Animals | 3 | 2023 | 20612 | 0.130 |
Why?
|
| Disease Models, Animal | 1 | 2023 | 2179 | 0.120 |
Why?
|
| Nanoparticles | 1 | 2021 | 513 | 0.120 |
Why?
|
| Gene Expression Regulation | 1 | 2022 | 1616 | 0.110 |
Why?
|
| Incidence | 1 | 2018 | 1376 | 0.110 |
Why?
|
| Phenotype | 1 | 2018 | 1199 | 0.110 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 2569 | 0.080 |
Why?
|
| Retrospective Studies | 1 | 2021 | 6638 | 0.080 |
Why?
|
| Adult | 2 | 2023 | 16791 | 0.070 |
Why?
|
| Aged | 1 | 2020 | 14393 | 0.050 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2023 | 48 | 0.050 |
Why?
|
| Antibodies | 1 | 2023 | 182 | 0.050 |
Why?
|
| DNA Nucleotidylexotransferase | 1 | 2021 | 12 | 0.050 |
Why?
|
| Genotype | 1 | 2022 | 664 | 0.040 |
Why?
|
| Linkage Disequilibrium | 1 | 2017 | 47 | 0.030 |
Why?
|
| Haplotypes | 1 | 2017 | 131 | 0.030 |
Why?
|
| Demography | 1 | 2017 | 173 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2019 | 383 | 0.030 |
Why?
|